An attempt to evaluate the effect of vitamin K3 using as an enhancer of anticancer agents

Sumio Matzno, Yuka Yamaguchi, Takeshi Akiyoshi, Toshikatsu Nakabayashi, Kenji Matsuyama

研究成果: Article査読

25 被引用数 (Scopus)

抄録

The possibility of vitamin K3 (VK3) as an anticancer agent was assessed. VK3 dose-dependently diminished the cell viability (measured as esterase activity) with IC50 of 13.7 μM and Hill coefficient of 3.1 in Hep G2 cells. It also decreased the population of S phase and arrested cell cycle in the G2/M phase in a dose-dependent manner. G2/M arrest was regulated by the increment of cyclin A/cdk1 and cyclin A/cdk2 complex, and contrasting cyclin B/cdk1 complex decrease. Finally, combined application demonstrated that VK3 significantly enhanced the cytotoxicity of etoposide, a G2 phase-dependent anticancer agent, whereas it reduced the cytotoxic activity of irinotecan, a S phase-dependent agent. These findings suggest that VK3 induces G 2/M arrest by inhibition of cyclin B/cdk1 complex formation, and is thus useful as an enhancer of G2 phase-dependent drugs in hepatic cancer chemotherapy.

本文言語English
ページ(範囲)1270-1273
ページ数4
ジャーナルBiological and Pharmaceutical Bulletin
31
6
DOI
出版ステータスPublished - 2008 6月
外部発表はい

ASJC Scopus subject areas

  • 薬理学
  • 薬科学

フィンガープリント

「An attempt to evaluate the effect of vitamin K3 using as an enhancer of anticancer agents」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル